Skip to main content

Attention-Deficit and Disruptive Behavior Disorders

  • Living reference work entry
  • First Online:
Encyclopedia of Psychopharmacology

Synonyms

Attention-deficit/hyperactivity disorder, ADHD

Definition

Attention-deficit/hyperactivity disorder (ADHD) affects about 8–12 % of school-age children, being more common in boys than in girls by a ratio of approximately 3:1. This condition is characterized by excessive inattention and impulsivity/hyperactivity for a given developmental level. In at least 50 % of cases, this condition produces enduring impairment in adulthood. ADHD has deleterious impact on several areas of social development such as educational attainment, family life, and occupational stability. ADHD has a strong hereditary basis, with genetic factors accounting for about 80 % of the phenotypic variance. Weak associations with ADHD have been reported for the 7-repeat polymorphism of the D4 dopaminergic receptor gene, the 10-repeat allele of the dopamine transporter (DAT1), alleles of the D2 and D5 dopaminergic receptors, the gene coding for catechol-O-methyl-transferase, and genes related to the noradrenergic...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366:237–248

    Article  PubMed  Google Scholar 

  • Faraone SV, Biederman J, Roe C (2002) Comparative efficacy of adderall and methylphenidate in attention deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol 22:468–473

    Article  CAS  PubMed  Google Scholar 

  • Findling RL (2008) Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Clin Ther 30:942–957

    Article  CAS  PubMed  Google Scholar 

  • Kunwar A, Dewan M, Faraone SV (2007) Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 8:555–562

    Article  CAS  PubMed  Google Scholar 

  • Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyan AN, Forehand G, Nguyen A, Waxmonsky J (1999) A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics 103:e43

    Article  CAS  PubMed  Google Scholar 

  • Rappley MD (2005) Attention deficit hyperactivity disorder. N Engl J Med 352:165–173

    Article  CAS  PubMed  Google Scholar 

  • Stein MA (2008) Treating adult ADHD with stimulants. CNS Spectr 13:8–11

    PubMed  Google Scholar 

  • Strange BC (2008) Once-daily treatment of ADHD with guanfacine: patient implications. Neuropsychiatr Dis Treat 4:499–506

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement (2001) Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108:1033–1044

    Article  Google Scholar 

  • Swanson JM, Volkow ND (2002) Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav Brain Res 130:73–78

    Article  CAS  PubMed  Google Scholar 

  • Swanson JM, Volkow ND (2003) Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 27:615–621

    Article  CAS  PubMed  Google Scholar 

  • Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa POD (2007) Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 17:39–59

    Article  PubMed  Google Scholar 

  • Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen A, DeCory HH, Hirshe Dirksen SJ, Hatch SJ, COMACS Study Group (2004) A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics 113:e206–e216

    Article  PubMed  Google Scholar 

  • The MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073–1086

    Article  Google Scholar 

  • Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325–1331

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francisco Aboitiz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Aboitiz, F., Castellanos, F.X., Carrasco, X. (2014). Attention-Deficit and Disruptive Behavior Disorders. In: Stolerman, I., Price, L. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27772-6_338-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27772-6_338-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27772-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics